Skip to main content
Top
Published in: Calcified Tissue International 4/2015

01-04-2015 | Original Research

Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone

Authors: S. Lomholt, A. K. Amstrup, E. Moser, N. F. B. Jakobsen, L. Mosekilde, P. Vestergaard, L. Rejnmark

Published in: Calcified Tissue International | Issue 4/2015

Login to get access

Abstract

Unexplained high bone mineral density (BMD) is a rare condition and the mechanisms responsible are yet to be described in detail. The aim of the study was to identify patients with unexplained high BMD from a local DXA database and compare their radiological phenotype with an age- and a gender-matched group of population-based controls. We defined high BMD as a DXA Z-score ≥ + 2.5 at the total hip and lumbar spine. We characterized the findings as “unexplained” if no osteodegenerative changes, bone metabolic disease, or arthritis at the hip or lumbar spine was observed. All participants were investigated with high-resolution peripheral quantitative computed tomography (HR-pQCT), QCT, DXA, fasting blood samples, a 24-h urine sample, and questionnaires. The DXA database contained data on 25,118 patients. Initially, 138 (0.55 %) potential participants with high BMD were identified, and during the study ten additional cases were identified from new DXA scans. Sixty-seven patients accepted to participate in the study, and among these we identified 15 women and one man with unexplained high BMD. These 15 women had higher BMD throughout the skeleton relative to controls, similar area/volume at the hip and the distal extremities, a higher number of trabeculae, which was thicker than in the controls, and a higher finite element estimated bone strength. The 15 women were heavier and had a higher fat mass then controls. We conclude that patients with unexplained high BMD have a generalized high BMD phenotype throughout their skeleton, which is characterized with a denser microarchitecture.
Literature
1.
4.
go back to reference Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 6:368–381CrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 6:368–381CrossRef
5.
go back to reference Blake GM, Fogelman I (1997) Interpretation of bone densitometry studies. Semin Nucl Med 3:248–260CrossRef Blake GM, Fogelman I (1997) Interpretation of bone densitometry studies. Semin Nucl Med 3:248–260CrossRef
6.
go back to reference Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 9588:657–666. doi:10.1016/s0140-6736(07)61342-7 CrossRef Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 9588:657–666. doi:10.​1016/​s0140-6736(07)61342-7 CrossRef
7.
go back to reference Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 4:508–516. doi:10.1210/er.2001-2002 CrossRef Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 4:508–516. doi:10.​1210/​er.​2001-2002 CrossRef
8.
go back to reference Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 19:1434–1441. doi:10.1056/nejm200105103441904 CrossRef Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 19:1434–1441. doi:10.​1056/​nejm200105103441​904 CrossRef
9.
go back to reference Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 8:756–765. doi:10.1056/NEJMoa0809493 CrossRef Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 8:756–765. doi:10.​1056/​NEJMoa0809493 CrossRef
10.
go back to reference Gregson CL, Steel SA, O’Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH (2012) ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int 2:643–654. doi:10.1007/s00198-011-1603-4 CrossRef Gregson CL, Steel SA, O’Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH (2012) ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int 2:643–654. doi:10.​1007/​s00198-011-1603-4 CrossRef
11.
go back to reference Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 1:11–19. doi:10.1086/338450 CrossRef Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 1:11–19. doi:10.​1086/​338450 CrossRef
13.
go back to reference Sarrion P, Mellibovsky L, Urreizti R, Civit S, Cols N, Garcia-Giralt N, Yoskovitz G, Aranguren A, Malouf J, Di Gregorio S, Rio LD, Guerri R, Nogues X, Diez-Perez A, Grinberg D, Balcells S (2014) Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women. PLoS One 4:e94607. doi:10.1371/journal.pone.0094607 CrossRef Sarrion P, Mellibovsky L, Urreizti R, Civit S, Cols N, Garcia-Giralt N, Yoskovitz G, Aranguren A, Malouf J, Di Gregorio S, Rio LD, Guerri R, Nogues X, Diez-Perez A, Grinberg D, Balcells S (2014) Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women. PLoS One 4:e94607. doi:10.​1371/​journal.​pone.​0094607 CrossRef
14.
go back to reference Whyte MP (2005) Misinterpretation of osteodensitometry with high bone density: BMD Z≥ or +2.5 is not “normal”. J Clin Densitom 1:1–6CrossRef Whyte MP (2005) Misinterpretation of osteodensitometry with high bone density: BMD Z≥ or +2.5 is not “normal”. J Clin Densitom 1:1–6CrossRef
15.
go back to reference Frost M, Andersen T, Gossiel F, Hansen S, Bollerslev J, van Hul W, Eastell R, Kassem M, Brixen K (2011) Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 8:1721–1728. doi:10.1002/jbmr.376 CrossRef Frost M, Andersen T, Gossiel F, Hansen S, Bollerslev J, van Hul W, Eastell R, Kassem M, Brixen K (2011) Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res 8:1721–1728. doi:10.​1002/​jbmr.​376 CrossRef
16.
go back to reference Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 20:1513–1521. doi:10.1056/NEJMoa013444 CrossRef Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 20:1513–1521. doi:10.​1056/​NEJMoa013444 CrossRef
17.
go back to reference Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatol (Oxford). doi:10.1093/rheumatology/ket007 Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatol (Oxford). doi:10.​1093/​rheumatology/​ket007
18.
go back to reference Gregson CL, Sayers A, Lazar V, Steel S, Dennison EM, Cooper C, Smith GD, Rittweger J, Tobias JH (2013) The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study. Bone 1:380–388. doi:10.1016/j.bone.2012.10.021 CrossRef Gregson CL, Sayers A, Lazar V, Steel S, Dennison EM, Cooper C, Smith GD, Rittweger J, Tobias JH (2013) The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study. Bone 1:380–388. doi:10.​1016/​j.​bone.​2012.​10.​021 CrossRef
19.
go back to reference Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L (2014) Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. doi:10.1007/s00223-014-9877-0 PubMed Jakobsen NF, Rolighed L, Moser E, Nissen PH, Mosekilde L, Rejnmark L (2014) Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif Tissue Int. doi:10.​1007/​s00223-014-9877-0 PubMed
20.
go back to reference Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 4:775–787. doi:10.1016/j.bone.2007.11.018 CrossRef Pothuaud L, Carceller P, Hans D (2008) Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 4:775–787. doi:10.​1016/​j.​bone.​2007.​11.​018 CrossRef
21.
go back to reference Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 3:518–530. doi:10.1002/jbmr.2176 CrossRef Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 3:518–530. doi:10.​1002/​jbmr.​2176 CrossRef
23.
go back to reference Laib A, Hauselmann HJ, Ruegsegger P (1998) In vivo high resolution 3D-QCT of the human forearm. Technol Health Care 5–6:329–337 Laib A, Hauselmann HJ, Ruegsegger P (1998) In vivo high resolution 3D-QCT of the human forearm. Technol Health Care 5–6:329–337
24.
go back to reference Laib A, Ruegsegger P (1999) Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone 1:35–39CrossRef Laib A, Ruegsegger P (1999) Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone 1:35–39CrossRef
26.
go back to reference Laib A, Newitt DC, Lu Y, Majumdar S (2002) New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images. Osteoporos Int 2:130–136CrossRef Laib A, Newitt DC, Lu Y, Majumdar S (2002) New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images. Osteoporos Int 2:130–136CrossRef
27.
go back to reference van Rietbergen B, Weinans H, Huiskes R, Odgaard A (1995) A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech 1:69–81CrossRef van Rietbergen B, Weinans H, Huiskes R, Odgaard A (1995) A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech 1:69–81CrossRef
28.
go back to reference Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Ruegsegger P (2002) Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 6:842–848CrossRef Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Ruegsegger P (2002) Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 6:842–848CrossRef
29.
go back to reference Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 9:1683–1690. doi:10.1373/clinchem.2005.052936 CrossRef Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 9:1683–1690. doi:10.​1373/​clinchem.​2005.​052936 CrossRef
30.
go back to reference Gregson CL, Paggiosi MA, Crabtree N, Steel SA, McCloskey E, Duncan EL, Fan B, Shepherd JA, Fraser WD, Smith GD, Tobias JH (2013) Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men. J Clin Endocrinol Metab 2:818–828. doi:10.1210/jc.2012-3342 CrossRef Gregson CL, Paggiosi MA, Crabtree N, Steel SA, McCloskey E, Duncan EL, Fan B, Shepherd JA, Fraser WD, Smith GD, Tobias JH (2013) Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men. J Clin Endocrinol Metab 2:818–828. doi:10.​1210/​jc.​2012-3342 CrossRef
32.
go back to reference Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H (2000) Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 2:124–129CrossRef Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H (2000) Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med 2:124–129CrossRef
33.
go back to reference Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 2:162–168CrossRef Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 2:162–168CrossRef
34.
go back to reference Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2:405–415CrossRef Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2:405–415CrossRef
36.
go back to reference Terzi R, Dindar S, Terzi H, Demirtas O (2014) Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. doi:10.1089/met.2014.0074 PubMed Terzi R, Dindar S, Terzi H, Demirtas O (2014) Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. doi:10.​1089/​met.​2014.​0074 PubMed
37.
go back to reference Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, Nan D, Llorca J, Gonzalez-Macias J (2010) Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause 5:955–961. doi:10.1097/gme.0b013e3181e39a15 CrossRef Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, Nan D, Llorca J, Gonzalez-Macias J (2010) Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause 5:955–961. doi:10.​1097/​gme.​0b013e3181e39a15​ CrossRef
38.
go back to reference Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD (2008) Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res 3:392–399. doi:10.1359/jbmr.071108 Boutroy S, Van Rietbergen B, Sornay-Rendu E, Munoz F, Bouxsein ML, Delmas PD (2008) Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res 3:392–399. doi:10.​1359/​jbmr.​071108
39.
go back to reference Chevalley T, Bonjour JP, van Rietbergen B, Ferrari S, Rizzoli R (2013) Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius. Bone. doi:10.1016/j.bone.2013.04.025 PubMed Chevalley T, Bonjour JP, van Rietbergen B, Ferrari S, Rizzoli R (2013) Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius. Bone. doi:10.​1016/​j.​bone.​2013.​04.​025 PubMed
40.
go back to reference Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R, Ferrari S (2012) Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab 11:4174–4181. doi:10.1210/jc.2012-2561 CrossRef Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R, Ferrari S (2012) Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab 11:4174–4181. doi:10.​1210/​jc.​2012-2561 CrossRef
Metadata
Title
Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone
Authors
S. Lomholt
A. K. Amstrup
E. Moser
N. F. B. Jakobsen
L. Mosekilde
P. Vestergaard
L. Rejnmark
Publication date
01-04-2015
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2015
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-9955-y

Other articles of this Issue 4/2015

Calcified Tissue International 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.